Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia

By Rodríguez M. J.   Díaz S.   Veral-Lonch M.   Dukes E.   Rejas J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2585-2596

Informa Healthcare

Access to resources Recommend Favorite

Methodological issues in undertaking independent cost-effectiveness analysis for NICE: the case of therapies for ADHD

By Griffin Susan  

The European Journal of Health Economics, Vol. 9, Iss. 2, 2008-05 ,pp. : 137-145

Springer Publishing Company

Access to resources Recommend Favorite

A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective

By Hommer A.   Wickstrøm J.   Friis M.M.   Steeds C.   Thygesen J.   Ferreras A.   Gouws P.   Buchholz P.  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1057-1063

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia

By Nherera L.   Calvert N.W.   DeMott K.   Humphries S.E.   Neil H.A.W.   Minhas R.   Thorogood M.  

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 529-536

Informa Healthcare

Access to resources Recommend Favorite

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US*

By Charles Meaghan St.   Minshall Michael E.   Pandya Bhavik J.   Baran Robert W.   Tunis Sandra L.  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1343-1353

Informa Healthcare

Access to resources Recommend Favorite